Strategic partnerships Navitas Life Sciences operates globally with a multi-country footprint and a focus on technology-enabled services, suggesting opportunities to upsell integrated regulatory, safety, and data management solutions to mid to large pharma and biotech clients looking for global consistency.

AI driven trials OneClinical platform leveraging AI and machine learning for near real-time data and analytics indicates potential for selling advanced data intelligence, real-world data utilization, and adaptive trial design services to sponsors pursuing faster, more efficient development timelines.

PV and safety leadership Recognized strengths in pharmacovigilance and drug safety services by IDC MarketScape and Everest Group create a compelling case for expanding safety and regulatory submissions work, including risk management and post-marketing surveillance for existing or new product launches.

Business expansion Recent leadership changes involving acquisitions and divestitures signal a dynamic corporate structure; identify clients who value stability and continuity while Navitas navigates transitions, offering continuity-focused risk mitigation and onboarding support services.

Industry networks Proprietary networks like pvnet pvconnect and labelnet present cross-sell opportunities to sponsors needing integrated labeling compliance, pharmacovigilance data capture, and end-to-end trial support across regulatory and clinical domains.